Literature DB >> 30546709

Rapid progression of coronary artery disease in a patient with retroperitoneal fibrosis.

Kotaro Oe1, Tsutomu Araki1, Tetsuo Konno2, Kenji Sakata2, Kenshi Hayashi2, Hidekazu Ino2, Masakazu Yamagishi2.   

Abstract

A 76-year-old woman with a history of hypertension and dyslipidemia was admitted to our hospital because of chest pain. On the basis of an electrocardiogram showing ST elevation in V1-3 leads, the patient was diagnosed with acute anterior myocardial infarction. Coronary angiography (CAG) revealed occlusions of the mid portion of the left anterior descending artery (LAD) and distal portion of the left circumflex artery (LCX). A paclitaxel-eluting stent was implanted in the LAD. Two weeks later, the patient complained of abdominal pain. A computed tomography (CT) scan showed a perivascular cuff around the abdominal aorta and F18-fluorodeoxyglucose positron-emission tomography with CT (FDG-PET/CT) scan showed increased tracer uptake around the abdominal aorta and aortic arch, suggestive of retroperitoneal fibrosis. The second CAG, performed on day 46, revealed occlusion of the posterolateral branch of the LCX and rapidly progressing stenosis of the proximal portion of the LCX. The patient was suspected of coronary arteritis and received oral corticosteroid therapy. The third CAG, performed on day 77, revealed occlusion of the posterior descending branch of the right coronary artery. The corticosteroid therapy was gradually tapered after discharge. The fourth CAG, performed 5 months later, did not show progression of the coronary lesions.

Entities:  

Keywords:  Coronary artery disease; Intravascular ultrasound; Retroperitoneal fibrosis

Year:  2011        PMID: 30546709      PMCID: PMC6265145          DOI: 10.1016/j.jccase.2011.05.001

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  1 in total

Review 1.  Myocardial ischemia as presenting manifestation of IgG4-related disease: a case-based review.

Authors:  Guillermo Delgado-García; Sergio Sánchez-Salazar; Erick Rendón-Ramírez; Mario Castro-Medina; Bárbara Sáenz-Ibarra; Álvaro Barboza-Quintana; María Azalea Loredo-Alanis; David Hernández-Barajas; Dionicio Galarza-Delgado
Journal:  Clin Rheumatol       Date:  2016-05-04       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.